Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Guangzhou Henovcom Bioscience Co. Ltd.

Clinical trials sponsored by Guangzhou Henovcom Bioscience Co. Ltd., explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

Parkinson's treatment could go monthly: new injection tested Results expected Dec 2026 (estimated)

Browse trials soon ready across all sponsors →

Not yet finished but already full! 1

Parkinson's treatment could go monthly: new injection tested

Disease control Ongoing

This early-stage study tests a new long-acting injection called HNC364, which turns into the Parkinson's drug rasagiline in the body. Researchers want to see how much of the drug gets into the bloodstream compared to taking rasagiline pills daily. The study involves 30 healthy ad…

Phase 1 • Sponsor: Guangzhou Henovcom Bioscience Co. Ltd. • Aim: Disease control

Last updated Jun 27, 2026 13:00 UTC